The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change+2.3% to $46.35
Predicted High$46.40at 4 months
Predicted Low$45.45in 2 weeks
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 19, 2026 8:30 pm
Neutral
EXC trends range-bound to
$46.35
(+2.3% from $45.30)
by Feb 2027.
dip-then-recover
ThesisLow-beta utility trading slightly below composite fair value with negative value/quality lenses but decent earnings track record. Expect gradual mean-reversion toward the $46-47 fair value anchor, with risk-on regime slightly capping upside as capital rotates elsewhere.
Invalidated ifBreak below $43.50 or above $48.50 on sustained volume invalidates the slow-drift thesis
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $45.30 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 19, 2026
—
$45.30at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Sep 2, 2026
$43.46–$47.14typical range · internal point $45.45
—
±4.1%
6/10
Mild drift up toward fair value, no catalysts
1 month
Sep 19, 2026
$42.63–$47.97typical range · internal point $45.65
—
±5.9%
6/10
Slow convergence, low-beta grinds higher
2 months
Oct 19, 2026
$45.90
—
+1.3%
5/10
Utility rotation as risk-on fatigue sets in
3 months
Nov 19, 2026
$46.20
—
+2.0%
5/10
Approaching composite fair value anchor
4 months
Dec 19, 2026
$46.40
—
+2.4%
4/10
Year-end defensive positioning supports price
5 months
Jan 19, 2027
$46.15
—
+1.9%
4/10
January earnings uncertainty caps upside
6 months
Feb 19, 2027
$46.35
—
+2.3%
4/10
Settles near fair value composite anchor
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$45.47
(+0.4%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.